Fundraising Fox
Hemeo
Amsterdam, NL · Founded 2019 · 3 employees on LinkedIn · 2 known investors
Find your way into Hemeo
Sign up to see every warm intro you have to Hemeo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hemeo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis. It is aimed at doctors managing coagulation complications, with the goal of reducing blood transfusions and improving patient survival.
Founders & leadership
Hemeo was founded in 2019 by Rene van den Ham.
Investors · 2
How we know: NLC's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeedMar 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Hemeo do?
- Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis. It is aimed at doctors managing coagulation complications, with the goal of reducing blood transfusions and improving patient survival.
- Who founded Hemeo?
- Hemeo was founded by Rene van den Ham in 2019.
- Who are Hemeo's investors?
- Hemeo's investors include NLC, Momentum.
- Where is Hemeo headquartered?
- Hemeo is headquartered in Amsterdam, NL.